Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

US Antimony Shares Surge on Supply Chain Developments and Strong Fundamentals

Felix Baarz by Felix Baarz
September 21, 2025
in Commodities, Penny Stocks, Trading & Momentum
0
US Antimony Stock
0
SHARES
119
VIEWS
Share on FacebookShare on Twitter

Shares of US Antimony Corporation experienced a dramatic single-day surge, climbing over 10% during Friday’s trading session. The rally appears driven by sector-wide developments in critical minerals and strengthening domestic supply chains, rather than company-specific news.

Impressive Weekly Performance and Trading Activity

The stock posted a substantial weekly gain of 11.8% by mid-week before closing Friday up 10.19% at $6.49 per share. Trading volume exceeded 2.6 million shares, indicating significantly heightened investor interest in the specialty metals company.

Sector Developments Fuel Momentum

While US Antimony itself didn’t release any corporate announcements, a significant development within the critical minerals sector provided the catalyst. Perpetua Resources received conditional approval for its Stibnite Gold Project in Idaho, which has the potential to become the United States’ sole source of antimony production. This mineral is essential for ammunition manufacturing and defense systems.

The situation is further intensified by China’s ongoing export restrictions on critical minerals, including antimony, highlighting the strategic importance of developing domestic production capabilities.

Should investors sell immediately? Or is it worth buying US Antimony?

Strong Financial Foundation

Recent financial results provide fundamental support for the share price movement. In Q2 2025, US Antimony reported a remarkable 160% revenue increase to $17.5 million, while net income surged 707% to $728,000.

The company operates the nation’s only antimony smelter in Montana and is actively expanding its operations through the reacquisition of mining claims and significant mineral rights in Alaska. This operational expansion aligns perfectly with national initiatives to reduce dependency on foreign sources of critical materials.

Technical Indicators and Market Sentiment

Technical indicators suggest continued strength following Friday’s significant price advance. Market experts had previously reaffirmed buy recommendations for the stock in August.

Investors are now turning their attention to the Q3 earnings report, anticipated in mid-November. Ongoing developments within the critical minerals sector are expected to maintain positive momentum for US Antimony shares in the coming weeks.

Ad

US Antimony Stock: Buy or Sell?! New US Antimony Analysis from March 25 delivers the answer:

The latest US Antimony figures speak for themselves: Urgent action needed for US Antimony investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

US Antimony: Buy or sell? Read more here...

Tags: US Antimony
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Lexaria Bioscience Stock
Healthcare

Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution

March 25, 2026
Ocugen Stock
Analysis

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Next Post
UPS Stock

Logistics Giant Faces Twin Setbacks as Downgrade and Failed Acquisition Hit Strategy

Broadcom Stock

Custom Chip Strategy Propels Broadcom to Record Heights

Capital Southwest Stock

Capital Southwest Gains Momentum with Strategic Refinancing and Major Stakeholder Backing

Recommended

Oracle Stock

Oracle Shares Face Sector-Wide Pressure Despite Solid Long-Term Chart

7 months ago
Telecommunications Industry stock Trading

Globalstar Forecasts Strong Financial Performance and Growth Initiatives for 2024

2 years ago
Pulmonx Corp Stock

Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast

5 months ago
Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Trending

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

by Jackson Burston
March 25, 2026
0

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned...

MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase
  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com